CHEMOTHERAPY NEUROTOXICITY ATTENUATION

This adverse event was reported 9 times

CHEMOTHERAPY NEUROTOXICITY ATTENUATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE 1 0.0003
1 AXICABTAGENE CILOLEUCEL 2 0.0002
2 RIZATRIPTAN BENZOATE 2 0.0002
3 IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 1 0.0002
4 PRIMIDONE 1 0.0001
5 CYTARABINE 2 0.0000
6 SODIUM OXYBATE 2 0.0000
7 ANTI-ITCH CREAM 2 0.0000
8 HYDROCORTISONE LOTION 2 0.0000
9 HYDROCORTISONE CREAM 1% 2 0.0000
See all drugs enriched for association with CHEMOTHERAPY NEUROTOXICITY ATTENUATION

CHEMOTHERAPY NEUROTOXICITY ATTENUATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD19-directed Chimeric Antigen Receptor [EPC] 2 0.0002
1 Human Immunoglobulin G [EPC] 1 0.0000
2 Topoisomerase Inhibitor [EPC] 1 0.0000
3 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
4 Expectorant [EPC] 2 0.0000
5 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
6 Alkylating Drug [EPC] 2 0.0000
7 Anti-epileptic Agent [EPC] 1 0.0000
8 Loop Diuretic [EPC] 2 0.0000
9 Platinum-based Drug [EPC] 1 0.0000
See all drug classes enriched for association with CHEMOTHERAPY NEUROTOXICITY ATTENUATION